UBS plans three-year contingent income autocallables linked to Amgen

By Susanna Moon

Chicago, April 15 – UBS AG, London Branch plans to price contingent income autocallable securities due April 25, 2019 linked to Amgen Inc. shares, according to an FWP filed with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 10.1% if Amgen stock closes at or above its downside threshold, 80% of their initial level, on the determination date for that quarter.

The notes will be called at par of $10 plus the contingent coupon if Amgen shares close above the initial level on any of the first 11 determination dates.

The payout at maturity will be par plus the final contingent coupon, unless Amgen shares finish below the 80% downside threshold, in which case investors will be fully exposed to any losses.

UBS Securities LLC is the agent, and Morgan Stanley Wealth Management is a distributor.

The notes will price on April 22 and settle on April 27.

The Cusip number is 90275R414.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.